Comments
Loading...
OncoCyte (NASDAQ:OCX) Stock Quotes, Forecast and News Summary
OncoCyte Stock (NASDAQ: OCX) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy OncoCyte (OCX) stock?
You can purchase shares of OncoCyte (NASDAQ:OCX) through any online brokerage.
Who are OncoCyte (OCX) competitors?
Other companies in OncoCyte’s space includes: Adverum Biotechnologies (NASDAQ:ADVM), Inozyme Pharma (NASDAQ:INZY), Burning Rock Biotech (NASDAQ:BNR), Aligos Therapeutics (NASDAQ:ALGS) and FibroGen (NASDAQ:FGEN).
What is the forecast, or price target, for OncoCyte (OCX) stock?
OncoCyte has a consensus price target of $3.35.
What is the current price for OncoCyte (OCX)?
The stock price for OncoCyte (NASDAQ: OCX) is $2.67 last updated February 21, 2025 at 10:39 AM EST.
Does OncoCyte (OCX) pay a dividend?
There are no upcoming dividends for OncoCyte.
When is OncoCyte (NASDAQ:OCX) reporting earnings?
OncoCyte’s Q1 earnings are confirmed for Wednesday, May 14, 2025.
Is OncoCyte (OCX) going to split?
There is no upcoming split for OncoCyte.
What sector and industry does OncoCyte (OCX) operate in?
OncoCyte is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.